- ISIN US55306V2051
- Country Kanada
Latest News
News Functions
Additional Functions
5 June 2013
MIV Therapeutics Inc.
MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER
23 October 2008
MIV Therapeutics Inc.
MIV Therapeutics Featured on Front Page of Medical Device Daily
MIV Therapeutics Inc.
JACC INTERVENTION PUBLISHES MIV’S VESTASYNC I TRIAL PRELIMINARY RESULTS
28 August 2008
MIV Therapeutics Inc.
MIV THERAPEUTICS FINISHES SUCCESSFUL ROADSHOW IN EUROPE AND PUBLISHES ANALYST’S STUDY
18 August 2008
MIV Therapeutics Inc.
MIV THERAPEUTICS ANNOUNCES EXCHANGE OFFER FOR REG S SHAREHOLDERS IN EUROPE
17 August 2008
MIV Therapeutics Inc.
MIV THERAPEUTICS ANNOUNCES EXCHANGE OFFER FOR REG S SHAREHOLDERS IN EUROPE
Upcoming Events
Latest Reports
News Functions
Additional Functions
22 September 2008
MIV Therapeutics Inc.
Corporate Presentation, September 2008
27 August 2008
MIV Therapeutics Inc.
Corporate Presentation, August 2008
4 July 2008
MIV Therapeutics Inc.
Annual Report for fiscal year ended: May 31, 2008
1 June 2008
MIV Therapeutics Inc.
Corporate Presentation, June 2008
15 May 2008
MIV Therapeutics Inc.
EuroPCR 2008: MIV Presentation Delivered by Mark Landy, President & CEO
12 December 2007
MIV Therapeutics Inc.
BMO 2007 Focus on Healthcare Conference Presentation